We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

8 hedge funds and large institutions have $123K invested in Zomedica Corp. in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

14% more funds holding

Funds holding: 7 → 8 (+1)

3% less capital invested

Capital invested by funds: $126K → $123K (-$3.42K)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCP
Gill Capital Partners
Colorado
+$325
2
HI
Harbour Investments
Wisconsin
+$263
3
ASN
Advisory Services Network
Georgia
+$215
4
BWL
Bogart Wealth LLC
Virginia
+$60

Top Sellers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
-$25.8K
2
EWA
EverSource Wealth Advisors
Alabama
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
JWM
1
Jackson Wealth Management
Florida
$76K – – –
ASN
2
Advisory Services Network
Georgia
$35.3K +$215 +1,800 +0.6%
AA
3
Ancora Advisors
Ohio
$9.98K -$25.8K -216,390 -72%
CA
4
CoreCap Advisors
Michigan
$573 – – –
GCP
5
Gill Capital Partners
Colorado
$325 +$325 +2,719 New
HI
6
Harbour Investments
Wisconsin
$263 +$263 +2,200 New
SIS
7
Sound Income Strategies
Florida
$112 – – –
BWL
8
Bogart Wealth LLC
Virginia
$81 +$60 +500 +278%
EWA
9
EverSource Wealth Advisors
Alabama
– -$1 -10 Closed

ZOM Hedge Fund Activity: Q1 2026 in Review

8 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2026, worth a combined $123K — down 2.7% from $126K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ZOM positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Gill Capital Partners, opening a new position worth an estimated $325. The largest seller was Ancora Advisors, cutting an estimated $25.8K.

  • 8 institutional investors held Zomedica Corp. (ZOM) as of Q1 2026, up from 7 in Q4 2025.
  • Funds reported $123K of Zomedica Corp. stock for Q1 2026, down 2.7% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q1 2026 and 1 closed out, a net change of +1 holder.
  • The largest Zomedica Corp. buyer in Q1 2026 was Gill Capital Partners, an estimated $325 added.
  • The largest Zomedica Corp. seller in Q1 2026 was Ancora Advisors, an estimated $25.8K sold.

Based on aggregated 13F filings for Q1 2026.